Flexion Therapeutics to Present at the RBC Capital Markets 2020 Virtual Global Healthcare Conference

Rhea-AI Summary

Flexion Therapeutics (Nasdaq: FLXN) announced that Dr. Michael Clayman, President and CEO, will engage in an analyst-led fireside chat at the RBC Capital Markets 2020 Virtual Global Healthcare Conference. This event is scheduled for 10:55 a.m. ET on May 19, 2020. To access the live webcast, visit Flexion's website. Flexion focuses on developing novel therapies for musculoskeletal conditions, primarily targeting osteoarthritis.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the RBC Capital Markets 2020 Virtual Global Healthcare Conference. The fireside chat is scheduled to begin at 10:55 a.m. ET on Tuesday, May 19, 2020.

To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.

About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Visit flexiontherapeutics.com.

Contact:

Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com

FAQ

When is Flexion Therapeutics participating in the RBC Capital Markets conference?

Flexion Therapeutics will participate in the RBC Capital Markets 2020 Virtual Global Healthcare Conference on May 19, 2020, at 10:55 a.m. ET.

Who will represent Flexion Therapeutics at the RBC Capital Markets conference?

Dr. Michael Clayman, the President and CEO of Flexion Therapeutics, will represent the company during the conference.

How can I access the Flexion Therapeutics conference webcast?

You can access the live webcast of the presentation on Flexion Therapeutics' website at ir.flexiontherapeutics.com.

What is the focus of Flexion Therapeutics?

Flexion Therapeutics is focused on developing and commercializing novel local therapies for treating musculoskeletal conditions, primarily osteoarthritis.

What stock symbol is associated with Flexion Therapeutics?

Flexion Therapeutics is traded under the stock symbol FLXN on Nasdaq.